Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 04, 2017
Elligo Health Research has received an award from the FDA to evaluate the use of harmonized data models to gather real-world data.
read more
Thursday, October 05, 2017
Many pharmaceutical manufacturers are switching to continuous production from batch methods.
read more
Therapix Biosciences has entered into an exclusive agreement with Catalent Pharma Solutions for the formulation, development and clinical manufacturing of THX-TS01.
read more
The FDA awarded 15 new clinical trial research grants totaling more than $22 million to boost development of products for patients with rare diseases.
read more
Cytel announced further expansion in Europe with the addition of an office in Basel, Switzerland.
read more
Aerie Pharmaceuticals has acquired from Envisia Therapeutics the rights to use PRINT technology in ophthalmology and certain other assets.
read more
Smithers Avanza named Peter Capozziello its new Director, Business Development.
read more
Avara has signed and closed on an agreement with AstraZeneca to acquire the Reims, France manufacturing and distribution facility.
read more
Marken announced the acquisition of Touchdown International a privately held specialty logistics company in Taiwan, for an undisclosed sum.
read more
Promethera Biosciences and Shibuya announced a strategic collaboration to establish a high-throughput, commercial-scale and clinical-grade cell therapy and regenerative medicine manufacturing platform.
read more
Tuesday, October 10, 2017
ShangPharma and SRI announced a collaboration to accelerate the development of innovative pharmaceuticals targeting neuroinflammation.
read more
Tuesday, October 10, 2017
Protea Biosciences announced it plans to develop clinical screening assays in various areas of oncology.
read more
Tuesday, October 10, 2017
Pertinax Pharma announced the commercial launch of its proprietary Pertinax technology, which provides controlled and sustained delivery of CHX.
read more
Tuesday, October 10, 2017
Nicox and pSivida announced their an agreement to explore the potential of combining Nicox's nitric oxide (NO)-donating compounds with pSivida's bioerodible sustained release drug delivery system.
read more
Tuesday, October 10, 2017
Protea Biosciences announced it plans to develop clinical screening assays in various areas of oncology.
read more